Palisade Bio, Inc. (PALI) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Palisade Bio reported revenue of $0. Net income was -$16.8M, or -$0.30 per diluted share. Operating activities generated -$10.8M of cash. At fiscal year end, Palisade Bio held $134.3M in total assets against $5.0M in total liabilities, including $133.4M of cash and equivalents.
Open the full interactive Palisade Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Palisade Bio Key Stats
| Share Price | $1.47 |
|---|---|
| Market Cap | $310.7M |
| 52-Week Range | $1.35 – $2.80 |
| Shares Outstanding | 211.4 million (basic, 2026 Q2) |
Palisade Bio Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $13,520 | $0 | $0 | $250,000 | $0 | $0 |
| Operating Income | -$10.7M | -$41.9M | -$15.7M | -$13.1M | -$14.9M | -$18.1M |
| Pre-Tax Income | -$16.3M | -$26.6M | -$14.3M | -$12.3M | -$14.4M | -$16.8M |
| Income Tax | — | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$16.3M | -$26.6M | -$14.3M | -$12.3M | -$14.4M | -$16.8M |
| Diluted EPS | -$5265.00 | -$2542.50 | -$247.95 | -$27.00 | -$10.19 | -$0.30 |
Palisade Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $500,000 |
| Net Income | -$2.9M | -$8.9M | -$9.6M | -$10.6M |
| Diluted EPS | -$0.38 | -$0.16 | -$0.05 | -$0.05 |
Palisade Bio Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.5M | $10.5M | $12.4M | $12.4M | $9.8M | $133.4M |
| Current Assets | $12.9M | $12.4M | $14.7M | $13.3M | $10.5M | $134.2M |
| Total Assets | $13.0M | $12.5M | $15.8M | $14.1M | $10.9M | $134.3M |
| Current Liabilities | $3.2M | $2.5M | $3.0M | $2.6M | $3.2M | $4.6M |
| Total Long-Term Debt | — | $174,000 | — | — | — | — |
| Total Liabilities | $3.3M | $5.1M | $3.3M | $2.7M | $3.4M | $5.0M |
| Shareholders' Equity | $9.8M | $7.4M | $12.5M | $11.3M | $7.5M | $129.4M |
Palisade Bio Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$9.0M | -$14.8M | -$13.4M | -$11.1M | -$12.2M | -$10.8M |
| Cash From Investing | — | -$54,000 | -$10,000 | -$4,000 | $0 | — |
| Cash From Financing | $14.5M | $24.6M | $15.3M | $11.2M | $9.6M | $134.4M |
| Free Cash Flow | — | -$14.8M | -$13.4M | -$11.1M | -$12.2M | — |
Figures from Palisade Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Palisade Bio financials page for every line item.
Palisade Bio Company Profile
| Ticker | PALI |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Carlsbad, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001357459 |
Frequently Asked Questions
What was Palisade Bio's revenue in fiscal 2025?
Palisade Bio (PALI) reported revenue of $0 for fiscal 2025.
What is Palisade Bio's annual revenue history?
Palisade Bio's annual revenue by fiscal year: 2020: $13,520; 2021: $0; 2022: $0; 2023: $250,000; 2024: $0; 2025: $0.
What was Palisade Bio's net income in fiscal 2025?
Palisade Bio reported net income of -$16.8M for fiscal 2025.
What was Palisade Bio's earnings per share (EPS) in fiscal 2025?
Palisade Bio's diluted EPS was -$0.30 for fiscal 2025 (adjusted for any later stock splits).
What was Palisade Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Palisade Bio reported revenue of $500,000.
How many shares of Palisade Bio are outstanding?
Palisade Bio reported a weighted average of 211.4 million basic shares outstanding in 2026 Q2.
What is Palisade Bio's market cap?
Based on its latest closing price, Palisade Bio (PALI) has a market capitalization of about $310.7M.
When does Palisade Bio's fiscal year end?
Palisade Bio's fiscal year end, as registered with the SEC, is December 31.
Where is Palisade Bio headquartered?
Palisade Bio lists its business address in Carlsbad, California in its SEC filings.
Palisade Bio Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →